| Value | ₹26.50 Cr |
|---|
BSE filing, NSE: MEDICAMEQ. Summary written from the filing by ALFA Finder's alert engine.
Medicamen Biotech Ltd: key numbers
- Share price
- ₹255.00
- Market cap
- ₹358.6 Cr
- Revenue (annual)
- ₹197.8 Cr
- Net profit (annual)
- ₹9.64 Cr
- P/E (TTM)
- 33.1×Sector 46.5×
- Promoter holding
- 42.57%+2.11% QoQ
- FII holding
- 4.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medicamen Biotech Ltd
All →Medicamen Biotech Preferential Issue
Medicamen Biotech allotted 50 lakh equity shares at ₹530 per share under its preferential issue. The allotment raises ₹265 Crore in fresh equity capital.
- Value
- ₹265.0 Cr
Medicamen Biotech Convertible Warrants
Medicamen Biotech allotted 5,00,000 equity shares to Shivalik Rasayan Ltd via warrant conversion at ₹530 each, raising ₹26.5 Crore. Paid-up capital rises to ₹14.06 Crore.
- Value
- ₹26.50 Cr
Medicamen Biotech Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Medicamen Biotech Other Announcement
Medicamen Biotech Limited's Director Sanjay Bansal sold 32,813 shares on the open market, as per a regulatory filing.
- Value
- ₹1.05 Cr
Medicamen Biotech Annual General Meeting
Medicamen Biotech Limited held its 33rd Annual General Meeting on September 26, 2026. The meeting concluded after discussing standard business and special resolutions.
Medicamen Biotech Annual General Meeting
Medicamen Biotech Limited filed its notice for the 33rd Annual General Meeting scheduled for September 26, 2026, alongside the Integrated Annual Report for FY 2025-26.
Other preferential issue announcements
All →CCME Global Preferential Issue
CCME Global's Preferential Issue Committee allotted about 15.08 crore equity shares worth Rs 150.84 crore, including shares for cash and for acquiring stakes in CCME UAE and Interlink. Both entities become associate and subsidiary respectively from October 28, 2026.
- Value
- ₹150.8 Cr
Sharp Investments Preferential Issue
Sharp Investment disclosed that its proposed preferential issue is solely to acquire 100% of RLCPL via share swap. The shares carry a nominal Rs.1 face value with no cash consideration.
Avalon Technologies Preferential Issue
Avalon Technologies intimated an EGM on 21 Nov 2026 seeking approval for AoA alterations and a preferential issue of 19,37,808 warrants to Zollner Elektronik AG. The warrants aggregate about ₹425 Crore at ₹2,193.20 each.
- Value
- ₹425.0 Cr
- Execution
- Warrants exercisable for 18 months from allotment
Kuber Udyog Preferential Issue
Kuber Udyog's board approved allotting equity shares and warrants on preferential basis, valued at 276.13 Crore. A share swap acquires 100% of Golden Ikon Fleet Management.
- Value
- ₹276.1 Cr
ACI Infocom Preferential Issue
ACI Infocom allotted 3.2 crore shares and 10 crore warrants to Sanjay & Rupal Mandavia at ₹1.53 each, a ~₹20.20 Crore preferential issue.
- Value
- ₹20.20 Cr
Sharvaya Metals Preferential Issue
Sharvaya Metals corrected its EGM notice on preferential issues of swap shares and warrants, totalling Rs 11.68 Crore. It updates disclosures before the November 6 meeting.
- Value
- ₹11.68 Cr